AstraZeneca PLC - American Depositary Shares (NQ:AZN)

92.77 UNCHANGED

Last Price Updated: 4:00 PM EST, Jan 30, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about AstraZeneca PLC - American Depositary Shares

< Previous 1 2

...

10 11 12 13 14 15 16 17 18

...

75 76 Next >

AZN DEADLINE: Investors Are Encouraged to Contact Kaplan Fox Before the Lead Plaintiff Deadline on February 21, 2025

January 14, 2025

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit Regulatory Compliance

AZN DEADLINE: Investors Are Encouraged to Contact Kaplan Fox Before the Lead Plaintiff Deadline on February 21, 2025

January 14, 2025

NEW YORK - January 14, 2025 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against AstraZeneca PLC (“AstraZeneca” or the “Company”) (NASDAQ: AZN) on...

Via TheNewswire.com

Topics Lawsuit Regulatory Compliance

AZN Class Action Notice: Robbins LLP Reminds Stockholders of the Lead Plaintiff Deadline in the AstraZeneca PLC Class Action

January 13, 2025

From Robbins LLP

Via GlobeNewswire

Better Buy: Novo Nordisk vs. AstraZeneca ↗

January 04, 2025

Via The Motley Fool

AZN Deadline to Lead in Securities Fraud Lawsuit is February 21, 2025 - Contact Kaplan Fox & Kilsheimer LLP

January 13, 2025

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Fraud Lawsuit Regulatory Compliance

AZN Deadline to Lead in Securities Fraud Lawsuit is February 21, 2025 - Contact Kaplan Fox & Kilsheimer LLP

January 13, 2025

NEW YORK - January 13, 2025 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against AstraZeneca PLC (“AstraZeneca” or the “Company”) (NASDAQ: AZN) on...

Via TheNewswire.com

Topics Fraud Lawsuit Regulatory Compliance

Datopotamab deruxtecan granted Priority Review in the US for patients with previously treated advanced EGFR-mutated non-small cell lung cancer

January 13, 2025

From AstraZeneca

Via Business Wire

Deadline to Lead in Securities Fraud Lawsuit Against AstraZeneca PLC (AZN) is February 21, 2025 - Contact Kaplan Fox & Kilsheimer LLP

January 11, 2025

NEW YORK - January 11, 2025 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against AstraZeneca PLC (“AstraZeneca” or the “Company”) (NASDAQ: AZN) on...

Via TheNewswire.com

Topics Fraud Lawsuit Regulatory Compliance

Deadline to Lead in Securities Fraud Lawsuit Against AstraZeneca PLC (AZN) is February 21, 2025 - Contact Kaplan Fox & Kilsheimer LLP

January 11, 2025

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Fraud Lawsuit Regulatory Compliance

Kaplan Fox & Kilsheimer LLP Alerts Investors to a Securities Class Action Against AstraZeneca PLC (AZN) - Deadline is February 21, 2025

January 10, 2025

NEW YORK - January 10, 2025 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against AstraZeneca PLC (“AstraZeneca” or the “Company”) (NASDAQ: AZN) on...

Via TheNewswire.com

Topics Lawsuit Regulatory Compliance

Kaplan Fox & Kilsheimer LLP Alerts Investors to a Securities Class Action Against AstraZeneca PLC (AZN) - Deadline is February 21, 2025

January 10, 2025

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit Regulatory Compliance

Lowey Dannenberg Notifies AstraZeneca PLC (“AstraZeneca” or the “Company”) (NASDAQ: AZN) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $200,000 in Losses to Contact the Firm

January 10, 2025

From Lowey Dannenberg, P.C.

Via GlobeNewswire

ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of AstraZeneca

January 10, 2025

From Faruqi & Faruqi LLP

Via GlobeNewswire

ROSEN, THE FIRST FILING FIRM, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – AZN

January 09, 2025

From The Rosen Law Firm PA

Via GlobeNewswire

Biotech Stocks Prepare For Action In 2025. Weight-Loss Drugs, AI And Trump 2.0 Are The Catalysts. ↗

January 09, 2025

Biotech stocks have seen three years of sideways to down trading. But obesity drugs, AI and Trump 2.0 promise to shake things up.

Via Investor's Business Daily

Topics Artificial Intelligence Government

3 Cheap Growth Stocks to Buy in 2025 ↗

January 09, 2025

Via The Motley Fool

Deadline Alert: AstraZeneca PLC (AZN) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit

January 08, 2025

From Glancy Prongay & Murray LLP

Via Business Wire

Deadline Approaching: AstraZeneca PLC (AZN) Investors Who Lost Money Urged To Contact Law Offices of Howard G. Smith

January 07, 2025

From Law Offices of Howard G. Smith

Via Business Wire

AZN INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that AstraZeneca PLC Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

January 07, 2025

From Robbins Geller Rudman & Dowd LLP

Via Business Wire

ROSEN, THE FIRST FILING FIRM, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – AZN

January 06, 2025

From The Rosen Law Firm PA

Via GlobeNewswire

Law Offices of Frank R. Cruz Encourages AstraZeneca PLC (AZN) Investors To Inquire About Securities Fraud Class Action

January 06, 2025

From The Law Offices of Frank R. Cruz

Via Business Wire

The Law Offices of Frank R. Cruz Continues Its Investigation of AstraZeneca PLC (AZN) on Behalf of Investors

January 06, 2025

From The Law Offices of Frank R. Cruz

Via Business Wire

AZN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that AstraZeneca PLC Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

January 05, 2025

From Bronstein, Gewirtz & Grossman, LLC

Via Business Wire

AZN INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that AstraZeneca PLC Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

January 03, 2025

From Robbins Geller Rudman & Dowd LLP

Via Business Wire

January 03, 2025

From Lowey Dannenberg, P.C.

Via GlobeNewswire

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Encourages AstraZeneca PLC (AZN) Investors to Inquire About Securities Fraud Class Action

January 03, 2025

From Glancy Prongay & Murray LLP

Via Business Wire

INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of AstraZeneca PLC (AZN) Investors

January 02, 2025

From Law Offices of Howard G. Smith

Via Business Wire

Chinese Cancer Drug Developer Hutchmed Sharpens R&D Focus, Divests Non-Core JV For Over $600 Million ↗

January 02, 2025

Hutchmed sells a 45% stake in SHPL for $608 million and focuses on advancing its cancer and immunology pipeline, including clinical trials by 2025.

Via Benzinga

DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors of AstraZeneca to Contact Us to Have Their Losses Evaluated Today

December 31, 2024

From Faruqi & Faruqi LLP

Via GlobeNewswire

AZN Investors Have Opportunity to Lead AstraZeneca PLC Securities Fraud Lawsuit with the Schall Law Firm

December 30, 2024

From The Schall Law Firm

Via Business Wire

< Previous 1 2

...

10 11 12 13 14 15 16 17 18

...

75 76 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.